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more, RNA was isolated to evaluate the response to ALK5 or
ALK1 signaling on expression of aggrecan, collagen type II and
MMP-13.
In addition, knee joints were isolated from mice aged 1 or 2
years, OA prone STR/ort mice (aged 3, 6 and 9 months and
1 year) and mice in which OA was induced by destabilizing
the medial meniscus (DMM model). Immunohistochemistry for
ALK5 and ALK1 was performed and the number of cells staining
positive for each receptor in tibial cartilage was measured with a
computerized imaging system.
Results: TGF-beta signaled in chondrocytes both via Smad2/3
and Smad1/5/8. Transfection of chondrocytes with caALK5
speciﬁcally led to Smad2/3 phosphorylation, whereas caALK1
speciﬁcally led to Smad1/5/8 phosphorylation. Chondrocytes
that over expressed caALK5 showed enhanced aggrecan ex-
pression and slightly reduced collagen type II expression. Chon-
drocytes over expressing caALK1 had elevated expression of
aggrecan, collagen type II and MMP-13, thereby displaying an
OA-phenotype.
From 1 year old to 2 year old mice ALK5 decreased 88% in the
medial tibial cartilage and 76% in the lateral tibial cartilage. ALK1
also was reduced, but only 51% in the medial tibial cartilage and
33% on the lateral side. In the DMM model no change was
observed on the lateral side, but a reduction of 91% ALK5
positive cells compared to 75% ALK1 positive cells in the OA
developing medial side. In the STR/ort model, the number of
cells staining positive for ALK5 was already reduced to 7% in the
medial tibial cartilage by 3 months of age. This rapidly declined
to less than 1% by 9 months. On the lateral side there was
still abundant ALK5 expression at 3 months of age, however,
this rapidly decreases in time to less than 10% by 9 months
and 1 year of age. ALK1 expression however, although slightly
decreased stayed relatively high and even increased again by 1
year of age compared to 9 months of age.
Overall a signiﬁcant increase in the ALK1/ALK5 ratio with age
and OA progression was demonstrated.
Conclusions: Our data show that ALK1 over expression in
chondrocytes induced an OA-like phenotype in chondrocytes.
Moreover, a clear switch of chondrocyte ALK5 to ALK1 expres-
sion was associated with ageing and OA progression. Our data
suggest a role for ALK1 in deviant chondrocyte behavior during
ageing and OA development.
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Purpose: The chondrocyte response to IGF-1 is reduced with
aging and in the development of OA, however, the mechanism
is not completely known. Activation of the PI3K/Akt pathway
is required for IGF-1 stimulation of proteoglycan synthesis and
likely also plays a role in survival signaling. Recently it has been
shown that TRB3, a tribbles homolog, inhibits IGF-1 activation of
Akt in HEK293 cells. The aim of this study was to determine if
a)TRB3 is expressed in chondrocytes and b) if it plays a role in
the reduced response to IGF-1 with aging or OA.
Methods: Adult human articular cartilage was obtained from
tissue donors (ages 19 to 83 graded on a 0-4 scale for degen-
erative changes) or from OA tissue removed at the time of joint
replacement. Proteins were either extracted directly from frozen,
pulverized tissue or chondrocytes were isolated from fresh tissue
by enzymatic digestion and cultured in high density monolayers.
Expression of TRB3 was analyzed by RT-PCR, immunoblotting,
and immunohistochemistry. Chondrocytes were transfected with
a TRB3 expression construct and the effects on cell survival
were determined in alginate beads at low density in serum-free
media (conditions in which the PI3K/Akt pathway is required for
survival).
Results: RT-PCR revealed that TRB3 is expressed in human
chondrocytes and the expression appeared to increase with
age. Immunoblotting of cartilage extracts could not conﬁrm an
age-related increase in TRB3 protein in normal tissue, however,
TRB3 protein levels were signiﬁcantly increased in chondrocytes
isolated from OA cartilage when compared to age-matched nor-
mal tissue. Likewise, TRB3 was detected in OA but not normal
tissue by immunohistochemistry. Overexpression of TRB3 in nor-
mal chondrocytes by transfection reduced survival by almost
50% when compared to cells transfected with an RFP control
plasmid. Overexpression of Akt in cells co-transfected with TRB3
was able to return survival back to control levels.
Conclusions: These results are the ﬁrst to demonstrate that
TRB3 is present in human OA cartilage and in isolated OA
chondrocytes. TRB3 has previously been shown to inhibit acti-
vation of Akt in response to IGF-1 and in the present studies
overexpression of TRB3 resulted in increased cell death. Thus,
TRB3 could play a role in the increased cell death noted in OA
cartilage. Further studies are examining if TRB3 also contributes
to reduced proteoglycan synthesis in response to IGF-I.
70
OSTEOARTHRITIS AND CHANGES IN MUSCLE QUALITY
A.L. Devonshire1, A. Bos1, E.J. Metter1, R. Conwit2,
F. Lauretani3, L. Ferrucci1, S.M. Ling1
1National Institute on Aging, Baltimore, MD; 2National Institute of
Neurological Disorders and Stroke, Bethesda, MD; 3Tuscany
Regional Health Agency, Florence, Italy
Purpose: To examine the relationship between osteoarthritis
(OA), muscle quality, and peripheral nerve function in the context
of a normative aging study.
Methods: Data from 184 participants (87 women and 97 men) of
a normative aging cohort study were analyzed. Participants were
categorized as OA or no OA based on self-reported osteoarthritis
of the knee or hip. Persistent and recent knee and hip symptoms
were assessed by validated questionnaires. Participants also
underwent a standardized exam for presence of abnormalities
of the knee and hip. Ten millimeter computed tomography (CT)
axial images of the right middle tibia and the middle thigh were
obtained and analyzed for whole fat density, muscle density, and
cross-sectional area (CSA) (Geanie software, version 2.1). Fat
mass and lean mass of the right leg were also measured by dual
energy x-ray absorptiometry. The right peroneal nerve conduc-
tion velocity (NCV) was measured at the popliteal fossa and the
ﬁbular head. Data was analyzed using SPSS software. Differ-
ences between groups were tested by ANCOVA for continuous
variables and chi-square for categorical variables. The relation-
ships between OA and muscle quality were further analyzed
using stepwise ANCOVA analyses that included age, sex, race,
height2, smoking, alcohol consumption, comorbidities, physical
activity, and peripheral nerve function as independent variables.
Results: Data from 58 participants with self-reported knee or
hip OA and 126 without OA were analyzed. As shown in Table
1, participants with OA were older (p=0.004) compared to those
without OA, and had proportionately higher percentages of indi-
viduals with current knee or hip pain (p<0.001) and knee or hip
pain on examination (p=0.001). The proportion of females and
the average BMI were similar between the two groups. Muscle
density of the middle tibia was signiﬁcantly lower in individuals
with self-reported knee or hip OA (Figure 1; p=0.004). This rela-
tionship persisted after adjustment for age, self-reported recent
knee and/or hip pain, knee and/or hip pain upon examination, and
